| Name | GSK1733953A |
|---|
| Description | DG70 (GSK1733953A), a biphenyl amide, is a respiration inhibitor in Mycobacterium tuberculosis, inhibits MenG activity with an IC50 value of 2.6 ± 0.6 μM. DG70 inhibits the catalytic methylation of Mycobacterium tuberculosis demethylmenaquinone methyltransferase enzymes. DG70 can be used for Tuberculosis (TB) research[1][2][3]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 2.6 ± 0.6 μM (MenG)[1] |
| References |
| Molecular Formula | C21H17ClFNO3 |
|---|---|
| Molecular Weight | 385.82 |
| Storage condition | 2-8°C |